Prasad Raju sold CRSP
January 6, 2026 · Form 4 insider transaction
Prasad Raju sold 5,004 shares of CRISPR Therapeutics AG at $60.00 per share, a transaction worth $300.2K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
5,004
Price
$60.00
Total value
$300.2K
InsiderPrasad Raju
RoleOfficer
SecurityCommon Shares
Transaction codeS: Open-market sale
Transaction dateJanuary 6, 2026
Filing dateJanuary 8, 2026
Shares owned after12,530
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2025.